Study of Pazopanib in the Treatment of Surgically Unresectable or Metastatic Liposarcoma
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Brian L Samuels, MD
Northwest Oncology
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
9 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Sarcoma Oncology Center
Santa Monica, California, United States
- Washington Cancer Institute
Washington D.C., District of Columbia, United States
- Kootenai Cancer Center
Post Falls, Idaho, United States
- Oncology Specialists, Sc
Niles, Illinois, United States
- University of Iowa
Iowa City, Iowa, United States
- University of Minnesota
Minneapolis, Minnesota, United States
- Pennsylvania Oncology Hematology Associates
Philadelphia, Pennsylvania, United States
- West Clinic
Memphis, Tennessee, United States
- Md Anderson Cancer Center
Houston, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Mar 2012
- Primary completion
- 31 Oct 2014
- Completion
- 31 Mar 2016
- Last update posted
- 15 Feb 2017
- Registered enrollment
- 42
- Registry id
- NCT01506596
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 4 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.